Fuminori Yamaguchi Selected Research

Fuminori Yamaguchi Research Topics

Disease

12	Neoplasms (Cancer) 11/2018 - 01/2005
6	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 02/2008
6	Insulin Resistance 01/2018 - 02/2011
5	Body Weight (Weight, Body) 11/2015 - 02/2011
5	Carcinoma (Carcinomatosis) 12/2014 - 07/2005
4	Hypoxia (Hypoxemia) 01/2017 - 05/2015
4	Hyperglycemia 11/2015 - 09/2012
4	Type 2 Diabetes Mellitus (MODY) 11/2015 - 02/2011
3	Obesity 11/2015 - 07/2014
2	Fibrosis (Cirrhosis) 01/2017 - 09/2012
2	Adenocarcinoma 01/2016 - 12/2014
2	Inflammation (Inflammations) 01/2016 - 05/2015
2	Reperfusion Injury 08/2013 - 01/2003
2	Whooping Cough (Pertussis) 06/2010 - 05/2010
2	Ovarian Neoplasms (Ovarian Cancer) 10/2007 - 07/2005
1	Periodontitis 08/2020
1	Dental Caries (Decay, Dental) 08/2020
1	Neuroblastoma 01/2016
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Weight Gain 11/2015
1	Hypertension (High Blood Pressure) 11/2015
1	Dyslipidemias (Dyslipidemia) 11/2015
1	Glucose Intolerance 11/2015
1	Atherosclerosis 11/2015
1	Body Weight Changes 01/2015
1	Head and Neck Neoplasms (Head and Neck Cancer) 11/2014
1	Neoplasm Metastasis (Metastasis) 02/2014
1	Hyperlipidemias (Hyperlipidemia) 01/2014
1	Anhidrotic Ectodermal Dysplasia 1 08/2013
1	Ischemia 08/2013
1	Pituitary Neoplasms (Pituitary Adenoma) 07/2012
1	With Papillary Renal Neoplasia Papillary Thyroid Carcinoma 05/2010
1	Squamous Cell Carcinoma of Head and Neck 08/2009
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2009
1	Leukemia 05/2009
1	Burkitt Lymphoma (Burkitt's Lymphoma) 05/2009
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2007
1	Atrophy 09/2007

Drug/Important Bio-Agent (IBA)

11	alloseIBA 01/2016 - 01/2003
11	SugarsIBA 11/2015 - 07/2005
10	Proteins (Proteins, Gene)FDA Link 11/2018 - 01/2005
9	psicose (D-psicose)IBA 11/2015 - 07/2005
5	ThioredoxinsIBA 11/2018 - 02/2008
5	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 08/2009
4	Insulin (Novolin)FDA Link 11/2015 - 02/2011
3	Blood Glucose (Blood Sugar)IBA 01/2015 - 02/2011
2	Dizocilpine Maleate (Dizocilpine)IBA 01/2022 - 10/2013
2	Excitatory Amino Acid AntagonistsIBA 01/2022 - 10/2013
2	Transcription Factors (Transcription Factor)IBA 03/2016 - 01/2005
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2016 - 12/2014
2	Indicators and Reagents (Reagents)IBA 01/2016 - 01/2005
2	FructoseIBA 01/2014 - 08/2009
2	Hematoxylin (Haematoxylon)IBA 08/2013 - 09/2012
2	Pertussis VaccineIBA 06/2010 - 05/2010
2	VaccinesIBA 06/2010 - 05/2010
2	MonosaccharidesIBA 09/2008 - 02/2008
1	tagatose (D-tagatose)IBA 08/2020
1	LipidsIBA 01/2018
1	Dactinomycin (Actinomycin)FDA LinkGeneric 01/2017
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2017
1	CateninsIBA 01/2017
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	1-Methyl-3-isobutylxanthine (1 Methyl 3 isobutylxanthine)IBA 01/2017
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 01/2017
1	Calcium-Binding ProteinsIBA 01/2016
1	isoamericanol AIBA 01/2016
1	LuciferasesIBA 01/2016
1	S100 Proteins (S 100 Protein)IBA 01/2016
1	Metformin (Glucophage)FDA LinkGeneric 11/2015
1	ThiazolidinedionesIBA 11/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2015
1	protein phosphatase 5IBA 12/2014
1	tissue-factor-pathway inhibitor 2 (PP5)IBA 12/2014
1	Docetaxel (Taxotere)FDA Link 11/2014
1	AdipokinesIBA 07/2014
1	AngiotensinsIBA 07/2014
1	Valsartan (Vals)FDA Link 07/2014
1	Type 1 Angiotensin ReceptorIBA 07/2014
1	ImmunophilinsIBA 02/2014
1	Tacrolimus Binding Proteins (FKBP)IBA 02/2014
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2013
1	2,3- dioxo- 6- nitro- 7- sulfamoylbenzo(f)quinoxaline (NBQX)IBA 10/2013
1	Glutamic Acid (Glutamate)FDA Link 10/2013
1	NMDA receptor A1IBA 10/2013
1	Coloring Agents (Dyes)IBA 08/2013
1	Eosine Yellowish-(YS) (Eosin)IBA 09/2012
1	Protein Kinases (Protein Kinase)IBA 07/2012
1	Pertussis ToxinIBA 05/2010
1	AntigensIBA 05/2010
1	pertactin FDA Link 05/2010
1	Thymidylate SynthaseIBA 09/2008
1	Fluorouracil (Carac)FDA LinkGeneric 09/2008
1	Culture MediaIBA 10/2007

Therapy/Procedure

2	Therapeutics 11/2018 - 09/2008
1	Caloric Restriction 11/2015
1	Glycemic Control 11/2015
1	Intravenous Administration 01/2014
1	Oral Administration 01/2014
1	Surgical Flaps 08/2013